Low serum aluminum values in dialysis patients with increased bone aluminum levels

Clinical Nephrology

Volumn 50, Issue 2, 1998, Pages 69-76

  Van Landeghem, G F ^a   D'Haese, P C ^a   Lamberts, L V ^a   Djukanovic, L ^b   Pejanovic, S ^b   Goodman, W G ^c   De Broe, M E ^a,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aluminum; Bone; Dialysis; Iron; Monitoring; Speciation

Indexed keywords

ALUMINUM; ALUMINUM HYDROXIDE; DIALYSIS FLUID; FERRITIN; IRON; PHOSPHATE; TRANSFERRIN;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD LEVEL; BONE LEVEL; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRON OVERLOAD; MALE;

EID: 0031659628     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Blaehr H, Madsen S, Rud Andersen J 1986 Effect of iron-loading on intestinal aluminum absorption in chronic renal insufficiency. In: Taylor A (ed). Aluminum and other Trace Elements in Renal Disease. Bailliere Tindall, London, pp 71-85
2. Brown TS, Schwartz R 1992 Aluminum accumulation in serum liver and spleen of iron-depleted and iron-adequate rats. Biol Trace Elem Res 34: 1-10
3. Cannata JB, Olaizola IR, Gomez-Alonso C, Menendez Fraga P, Alonso-Suarez M, Diaz-Lopez JB 1993 Serum aluminum transport and aluminum uptake in chronic renal failure: role of iron and aluminum metabolism. Nephron 65: 141-146
4. Cannata JB, Fernandez-Soto I, Fernandez-Menendez MJ, Fernandez-Martin JL, McGregor DJ, Brock JH, Halls D 1991 Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int 39: 799-803
5. Christoffersen MR, Christoffersen J 1985 The effect of aluminum on the rate of dissolution of calcium hydroxyapatite - A contribution to the understanding of aluminum-induced bone diseases. Calcif Tissue Int 37: 673-676
6. Christoffersen MR, Thyregod HC, Christoffersen J 1987 Effects of aluminum (III), chromium (III), and iron (III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine. Calcif Tissue Int 41: 27-30
7. Coburn JW, Norris KC 1986 Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine. Sem Nephrol 6: 12-21
8. Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman WG, Verpooten GA, De Broe ME 1996 Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 11: 1065-1072
9. D'Haese PC, Van de Vyver FL, de Wolff FA, De Broe ME 1985 Measurement of aluminum in serum, blood, urine, and tissues of chronic hemodialyzed patients by use of electrothermal atomic abortion spectrometry. Clin Chem 31: 24-29
10. D'Haese PC, Couttenye MM, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME 1995 Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminum-related bone disease, increased risk for aluminum toxicity, or aluminum over-load. Nephrol Dial Transplant 10: 1874-1884
11. Farrar G, Altmann P, Welch S, Wychry O, Ghose B, Lejeune J, Corbett J, Prasher V, Blair JA 1990 Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminum in the brain. Lancet 335: 747-750
12. Ganrot PO 1986 Metabolism and possible health effects of aluminum. Environm Hlth Persp 65: 363-441
13. Greger JL, Chang MM, Macneil Radzanowski G 1995 Comparison of tissue retention of aluminum and Ga-67: effects of iron status in rats. Toxicology 100: 1-9
14. Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM 1994 Alzheimer's-like changes in tau protein processing: association with aluminum accumulation in brains of renal dialysis patients. Lancet 343: 993-997
15. Huang JY, Huang CC, Lim PS, Wu MS, Leu ML 1992 Effect of body iron stores on serum aluminum level in hemodialysis patients. Nephron 61: 158-162
16. Ittel TH, Schulpin A, Siebert HG 1991 Body iron stores do not affect the enhanced intestinal absorption of aluminum in uremia. J Am Soc Nephrol 2: 611
17. Ittel TH, Kinzel S, Ortmanns A, Sieberth H-G 1996 Effect of iron status on the intestinal absorption of aluminum: A reappraisal. Kidney Int 50: 1879-1888
18. Maitana T, Kubota H, Hhori N, Yoshihara K, Takeda M 1994 Distribution and urinary excretion of aluminum injected with several organic acids into mice: relationship with chemical state in serum studied by the HPLC-ICP method. J Appl Toxicol 14: 257-261
19. Martin CN, Osmond C, Edwardson JA, Barker DJP, Harris EC, Lacey RF 1989 Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet i: 59-62
20. Ohman L, Martin BR 1994 Citrate as the main small molecule binding Al in serum. Clin Chem 40: 598-601
21. Parfitt M, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 2: 595-610
22. Quartley B, Esselmont G, Taylor A, Dobrota M 1993 Effect of oral aluminum citrate on short-term tissue distribution of aluminum. Fd Chem Toxic 8: 543-548
23. Salusky JB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG 1988 Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33: 975-982
24. Simoes JC, Barata JD, D'Haese PC, De Broe ME 1994 Cela n'arrive qu'aux autres. Nephrol Dial Transplant 9: 67-68
25. Smans KA, Van Landeghem GF, D'Haese PC, Couttenye MM, De Broe ME 1996 Is there a link between erythropoietin therapy and adynamic bone disease? Nephrol Dial Transplant 11: 1248-1249
26. Thomas WC, Meyer JL 1984 Aluminum induced osteomalacia: an explanation. Am J Nephrol 4: 201-205
27. Trapp GA 1983 Plasma aluminum is bound to transferrin. Life Sci 33: 311-316
28. van Ginkel MF 1991 Aluminum metabolism and neurotoxicity: a role for citrate (Ph.D-thesis). Leiden, The Netherlands
29. Van Landeghem GF, D'Haese PC, Lamberts LV, De Broe ME 1997 Competition of iron and aluminum for transferrin: The molecular basis for aluminum deposition in iron-overloaded dialysis patients. Exp Nephrol 5: 239-245
30. Vanuytsel JL, D'Haese PC, Couttenye MM, De Broe ME 1992 Higher serum aluminum levels in iron-depleted dialysis patients. Nephrol Dial Transplant 7: 177 (Letter)
31. Zachee P, Boogaerts MA, Lins R, Daelemans R, Henckens M, De Broe ME 1990 Erythropoietin, aluminum, and anemia in patients on haemodialysis. Lancet 335: 1038-1039 (Letter)